StonvexLoading…
StonvexStonvexStonvexCore line items from BC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.38B | $5.36B | $4.03B | $2.67B |
Operating Income | $50.30M | $-40.70M | $-82.60M | $159.60M |
Net Income | $21.00M | $-137.30M | $-156.00M | $59.30M |
EPS (Diluted) | $0.32 | $-2.08 | $-2.36 | $1.20 |
Total Assets | $5.51B | $5.31B | $5.41B | $5.79B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $277.80M | $256.80M | $297.70M | $315.70M |
Free Cash Flow OCF − CapEx | $-121.30M | $396.30M | $312.70M | $206.20M |
Shares Outstanding | 65.01M | 64.89M | 65.10M | 65.48M |